Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 5
2021 8
2022 12
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Curcumin-piperine co-supplementation and human health: A comprehensive review of preclinical and clinical studies.
Heidari H, Bagherniya M, Majeed M, Sathyapalan T, Jamialahmadi T, Sahebkar A. Heidari H, et al. Phytother Res. 2023 Apr;37(4):1462-1487. doi: 10.1002/ptr.7737. Epub 2023 Jan 31. Phytother Res. 2023. PMID: 36720711 Review.
Despite its safety and potential for use against various diseases, curcumin's utility is restricted due to its low oral bioavailability. ...Further high-quality clinical trial studies are needed to firmly establish the clinical efficacy of the curcu …
Despite its safety and potential for use against various diseases, curcumin's utility is restricted due to its low oral bioava …
The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19-Results from a pragmatic randomized clinical trial.
Ujjan ID, Khan S, Nigar R, Ahmed H, Ahmad S, Khan A. Ujjan ID, et al. Front Nutr. 2023 Jan 18;9:1023997. doi: 10.3389/fnut.2022.1023997. eCollection 2022. Front Nutr. 2023. PMID: 36742008 Free PMC article.
Both CUR and QUE have shown inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in in vitro assays. OBJECTIVE: In the present study we aimed to assess the possible treatment benefits of a combined curcumin and quercetin (CUR-QUE) …
Both CUR and QUE have shown inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in in vitro assa …
The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial.
Askari G, Sahebkar A, Soleimani D, Mahdavi A, Rafiee S, Majeed M, Khorvash F, Iraj B, Elyasi M, Rouhani MH, Bagherniya M. Askari G, et al. Trials. 2022 Jun 6;23(1):472. doi: 10.1186/s13063-022-06375-w. Trials. 2022. PMID: 35668500 Free PMC article. Clinical Trial.
METHODS: Forty-six outpatients with COVID-19 disease were randomly allocated to receive two capsules of curcumin-piperine; each capsule contained 500 mg curcumin plus 5 mg piperine or placebo for 14 days. ...CONCLUSION: The present study results showed …
METHODS: Forty-six outpatients with COVID-19 disease were randomly allocated to receive two capsules of curcumin-piperi …
A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients.
Hassaniazad M, Eftekhar E, Inchehsablagh BR, Kamali H, Tousi A, Jaafari MR, Rafat M, Fathalipour M, Nikoofal-Sahlabadi S, Gouklani H, Alizade H, Nikpoor AR. Hassaniazad M, et al. Phytother Res. 2021 Nov;35(11):6417-6427. doi: 10.1002/ptr.7294. Epub 2021 Sep 19. Phytother Res. 2021. PMID: 34541720 Free PMC article. Clinical Trial.
In this study, we investigated the effect of curcumin nanomicelles on clinical outcome and cellular immune responses subtypes changes in COVID-19 patients. A randomized, triple-blinded, placebo-controlled study was done. Forty COVID-19 patients …
In this study, we investigated the effect of curcumin nanomicelles on clinical outcome and cellular immune responses subtypes changes …
Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Askari G, Alikiaii B, Soleimani D, Sahebkar A, Mirjalili M, Feizi A, Iraj B, Bagherniya M. Askari G, et al. Trials. 2021 Jul 6;22(1):434. doi: 10.1186/s13063-021-05372-9. Trials. 2021. PMID: 34229742 Free PMC article.
OBJECTIVES: This study aims to investigate the efficacy of curcumin-piperine co-supplementation on oxidative stress factors, clinical symptoms, and mortality rate in patients with coronavirus (COVID-19) admitted to the intensive care unit (ICU). TRIAL DESIGN: …
OBJECTIVES: This study aims to investigate the efficacy of curcumin-piperine co-supplementation on oxidative stress factors, clinical …
Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial.
Asadirad A, Nashibi R, Khodadadi A, Ghadiri AA, Sadeghi M, Aminian A, Dehnavi S. Asadirad A, et al. Phytother Res. 2022 Feb;36(2):1023-1031. doi: 10.1002/ptr.7375. Epub 2022 Jan 17. Phytother Res. 2022. PMID: 35040210 Clinical Trial.
The present study conducted a placebo-controlled clinical trial to evaluate the impact of nano-curcumin on the inflammatory cytokines in mild-to-moderate hospitalized COVID-19 patients. A total of 60 COVID-19 patients were randomly …
The present study conducted a placebo-controlled clinical trial to evaluate the impact of nano-curcumin on the inflamma …
Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial.
Pawar KS, Mastud RN, Pawar SK, Pawar SS, Bhoite RR, Bhoite RR, Kulkarni MV, Deshpande AR. Pawar KS, et al. Front Pharmacol. 2021 May 28;12:669362. doi: 10.3389/fphar.2021.669362. eCollection 2021. Front Pharmacol. 2021. PMID: 34122090 Free PMC article.
Background: Coronavirus disease-2019 (COVID-19) has a wide range of pathophysiological effects. Curcumin, an active constituent of Curcuma longa (turmeric), has several properties, including anti-inflammatory, antioxidant, antiviral, anti-thrombotic, and anti …
Background: Coronavirus disease-2019 (COVID-19) has a wide range of pathophysiological effects. Curcumin, an active con …
Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial.
Miryan M, Bagherniya M, Sahebkar A, Soleimani D, Rouhani MH, Iraj B, Askari G. Miryan M, et al. Trials. 2020 Dec 17;21(1):1027. doi: 10.1186/s13063-020-04924-9. Trials. 2020. PMID: 33334357 Free PMC article.
OBJECTIVES: This study aims to investigate the efficacy of curcumin-piperine co-supplementation on disease duration, severity and clinical symptoms, and inflammatory mediators in patients with coronavirus (COVID-19). TRIAL DESIGN: This is a randomized, placeb …
OBJECTIVES: This study aims to investigate the efficacy of curcumin-piperine co-supplementation on disease duration, severity and cli …
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.
Hassaniazad M, Inchehsablagh BR, Kamali H, Tousi A, Eftekhar E, Jaafari MR, Fathalipour M, Nikoofal-Sahlabadi S, Gouklani H, Alizade H, Nikpoor AR. Hassaniazad M, et al. Trials. 2020 Oct 22;21(1):876. doi: 10.1186/s13063-020-04824-y. Trials. 2020. PMID: 33092653 Free PMC article. Clinical Trial.
OBJECTIVES: To investigates the effectiveness of curcumin-containing Nanomicelles as a therapeutic supplement in the treatment of patients with COVID-19 and its effect on immune responses balance changes following treatment. TRIAL DESIGN: This study is conduc …
OBJECTIVES: To investigates the effectiveness of curcumin-containing Nanomicelles as a therapeutic supplement in the treatment of pat …
Promising clinical outcomes of nano-curcumin treatment as an adjunct therapy in hospitalized COVID-19 patients: A randomized, double-blinded, placebo-controlled trial.
Sadeghizadeh M, Asadollahi E, Jahangiri B, Yadollahzadeh M, Mohajeri M, Afsharpad M, Najafi F, Rezaie N, Eskandari M, Tavakoli-Ardakani M, Feizabadi F, Masjedi MR. Sadeghizadeh M, et al. Phytother Res. 2023 Aug;37(8):3631-3644. doi: 10.1002/ptr.7844. Epub 2023 Apr 29. Phytother Res. 2023. PMID: 37118944 Clinical Trial.
Curcumin with its powerful anti-inflammatory and antiviral properties could serve as a possible COVID-19 therapy. ...Hydroxychloroquine (HCQ) plus sofosbuvir was routinely administered to all 42 COVID-19 patients, who were randomly assigned to r …
Curcumin with its powerful anti-inflammatory and antiviral properties could serve as a possible COVID-19 therapy. ...Hy …
34 results